Anna G. Komarova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna G. Komarova has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
- N. M. Krivosheeva
Botkin Hospital
7 shared publications - S. A. Bliznyuk
Botkin Hospital
7 shared publications - Sergey Yakovlev
Botkin Hospital
6 shared publications - A. D. Gvozdeva
Botkin Hospital Moscow Russia
4 shared publications - Denis Anatolevich Andreev
Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - E. A. Naryshkina
Botkin Moscow Multidisciplinary Research and Clinical Center; Russian Medical Academy of Continuous Professional Education
3 shared publications
Latest Publications
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Visual and spatial disorders and their relationship with vestibular disorders in patients with ischemic stroke
Objective. To evaluate visual-spatial disorders (VSDs) and vestibular disorders, as well as their interrelationship in patients with ischemic stroke (IS). Material and methods. The study included 60 patients (27 males and 33 females; mean age 60.1±12.2 years) in the early recovery phase of IS. Of these, 23 experienced IS in the right carotid system, 18 in the left carotid system, and 19 in the vertebral-basilar system. The mean score on the National Institutes of Health Stroke Scale (NIHSS) was 3.7. Comprehensive neuropsychological and neurovestibular testing was conducted for all study patients. Results. VSDs were identified in 43 patients (71.7%) post-IS, with the highest prevalence observed in strokes affecting the right carotid system, accounting for 44.2% of all cases with VSDs. Notably, 29 patients (67.4%) with VSDs exhibited vestibular symptoms. Additionally, disorders of the central vestibular-oculomotor responses (CVOR) were observed in 40 patients (93%) with VSDs. A significant correlation between CVOR disorders and VSDs was documented, especially among patients with IS in the carotid system. VSDs was shown to diminish the quality of life in post-IS patients markedly. Conclusion. VSDs in post-IS patients may contribute to vestibular complications and adversely affect overall quality of life. The timely identification and management of VSD and vestibular disorders in this patient population are crucial for enhancing the efficacy of medical rehabilitation strategies.
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Visual and spatial disorders and their relationship with vestibular disorders in patients with ischemic stroke
Objective. To evaluate visual-spatial disorders (VSDs) and vestibular disorders, as well as their interrelationship in patients with ischemic stroke (IS). Material and methods. The study included 60 patients (27 males and 33 females; mean age 60.1±12.2 years) in the early recovery phase of IS. Of these, 23 experienced IS in the right carotid system, 18 in the left carotid system, and 19 in the vertebral-basilar system. The mean score on the National Institutes of Health Stroke Scale (NIHSS) was 3.7. Comprehensive neuropsychological and neurovestibular testing was conducted for all study patients. Results. VSDs were identified in 43 patients (71.7%) post-IS, with the highest prevalence observed in strokes affecting the right carotid system, accounting for 44.2% of all cases with VSDs. Notably, 29 patients (67.4%) with VSDs exhibited vestibular symptoms. Additionally, disorders of the central vestibular-oculomotor responses (CVOR) were observed in 40 patients (93%) with VSDs. A significant correlation between CVOR disorders and VSDs was documented, especially among patients with IS in the carotid system. VSDs was shown to diminish the quality of life in post-IS patients markedly. Conclusion. VSDs in post-IS patients may contribute to vestibular complications and adversely affect overall quality of life. The timely identification and management of VSD and vestibular disorders in this patient population are crucial for enhancing the efficacy of medical rehabilitation strategies.
- Open Access
- 7 September 2026
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 28 (3) , 54-76
Transplant Program at Botkin Hospital: Experience with 1,000 Solid Organ Transplants
Objective: to analyze the organizational strategies and clinical outcomes of the Organ Transplant Department at Botkin Hospital following the milestone of 1,000 solid organ transplants. Materials and methods . A retrospective analysis of the center’s transplant activities was conducted for the period 2018–2025, covering kidney, liver, and heart transplants. Donor and recipient characteristics, perioperative variables, and short- and long-term clinical outcomes were examined. Particular attention was given to the development of an integrated patient care pathway and organizational solutions that ensured continuity of specialized care at every stage, from candidate selection and pretransplant preparation to transplantation, postoperative management, and long-term follow-up. Advanced technologies were implemented to expand the donor pool, optimize perioperative management, and reduce the incidence of transplant-related complications. Results . Over a 7-year period, more than 1,000 solid organ trans-plants were performed. Despite a steady increase in transplant volume, excellent short- and long-term clinical outcomes were consistently maintained. The majority of grafts were procured from deceased donors, including a substantial proportion from expanded-criteria donors. Most recipients presented with severe comorbidities. The implementation of a comprehensive multidisciplinary care model, integrating specialists from diverse medical disciplines within a single transplant department, ensured continuity of patient care. The adoption of modern techniques enhanced the efficiency of the transplant program, reduced the risk of graft dysfunction, and minimized the incidence of both transplant-specific and general postoperative complications. Conclusion. The transplant program at Botkin Hospital represents a comprehensive model that integrates clinical activities, scientific research, and the training of young transplant specialists. Seven years of experience have demonstrated the effectiveness and sustainability of the developed strategies, the sustainability of achieved results, and their significant practical value for the continued advancement of transplant services within the national healthcare system.
- 7 September 2026
- Published by V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs in Russian Journal of Transplantology and Artificial Organs
- Vol. 28 (3) , 54-76
Open AccessTransplant Program at Botkin Hospital: Experience with 1,000 Solid Organ Transplants
Objective: to analyze the organizational strategies and clinical outcomes of the Organ Transplant Department at Botkin Hospital following the milestone of 1,000 solid organ transplants. Materials and methods . A retrospective analysis of the center’s transplant activities was conducted for the period 2018–2025, covering kidney, liver, and heart transplants. Donor and recipient characteristics, perioperative variables, and short- and long-term clinical outcomes were examined. Particular attention was given to the development of an integrated patient care pathway and organizational solutions that ensured continuity of specialized care at every stage, from candidate selection and pretransplant preparation to transplantation, postoperative management, and long-term follow-up. Advanced technologies were implemented to expand the donor pool, optimize perioperative management, and reduce the incidence of transplant-related complications. Results . Over a 7-year period, more than 1,000 solid organ trans-plants were performed. Despite a steady increase in transplant volume, excellent short- and long-term clinical outcomes were consistently maintained. The majority of grafts were procured from deceased donors, including a substantial proportion from expanded-criteria donors. Most recipients presented with severe comorbidities. The implementation of a comprehensive multidisciplinary care model, integrating specialists from diverse medical disciplines within a single transplant department, ensured continuity of patient care. The adoption of modern techniques enhanced the efficiency of the transplant program, reduced the risk of graft dysfunction, and minimized the incidence of both transplant-specific and general postoperative complications. Conclusion. The transplant program at Botkin Hospital represents a comprehensive model that integrates clinical activities, scientific research, and the training of young transplant specialists. Seven years of experience have demonstrated the effectiveness and sustainability of the developed strategies, the sustainability of achieved results, and their significant practical value for the continued advancement of transplant services within the national healthcare system.
- 15 August 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (9S)
Myocardial infarction without obstructive coronary artery disease in a patient taking zolmitriptan. A case report
Introduction . Triptans are first-line medications for acute migraine attacks. Their pharmacological action is due to the selective activation of serotonin 5-HT1B/1D receptors, leading to vasoconstriction of cerebral vessels and pain relief. However, a similar vasoconstrictor effect also occurs in the coronary arteries, which specifies their contraindications in patients with coronary artery disease and prior myocardial infarction (MI). Despite this, in individuals without cardiovascular disease, triptans are traditionally considered safe drugs with an extremely low risk of cardiovascular events. Brief description . This is a clinical case of non-obstructive coronary myocardial infarction complicated by transient third-degree atrioventricular block in a 44-year-old patient with no history of cardiovascular disease or risk factors. Ischemic myocardial injury was verified by contrast-enhanced cardiac magnetic resonance imaging, while coronary angiography revealed intact coronary arteries. Taking into account the temporal association and ruling out of alternative causes, coronary vasospasm was considered the most likely mechanism of MI. No recurrence of symptoms or conduction disorders was observed after zolmitriptan discontinuation. Discussion . This case demonstrates a rare complication of zolmitriptan therapy in a patient with no cardiovascular risk factors. Despite the favorable safety profile of triptans, their use, especially at higher doses, can lead to coronary vasospasm and life-threatening complications.
- 15 August 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (9S)
Myocardial infarction without obstructive coronary artery disease in a patient taking zolmitriptan. A case report
Introduction . Triptans are first-line medications for acute migraine attacks. Their pharmacological action is due to the selective activation of serotonin 5-HT1B/1D receptors, leading to vasoconstriction of cerebral vessels and pain relief. However, a similar vasoconstrictor effect also occurs in the coronary arteries, which specifies their contraindications in patients with coronary artery disease and prior myocardial infarction (MI). Despite this, in individuals without cardiovascular disease, triptans are traditionally considered safe drugs with an extremely low risk of cardiovascular events. Brief description . This is a clinical case of non-obstructive coronary myocardial infarction complicated by transient third-degree atrioventricular block in a 44-year-old patient with no history of cardiovascular disease or risk factors. Ischemic myocardial injury was verified by contrast-enhanced cardiac magnetic resonance imaging, while coronary angiography revealed intact coronary arteries. Taking into account the temporal association and ruling out of alternative causes, coronary vasospasm was considered the most likely mechanism of MI. No recurrence of symptoms or conduction disorders was observed after zolmitriptan discontinuation. Discussion . This case demonstrates a rare complication of zolmitriptan therapy in a patient with no cardiovascular risk factors. Despite the favorable safety profile of triptans, their use, especially at higher doses, can lead to coronary vasospasm and life-threatening complications.
- 5 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (7)
Probability of obstructive coronary atherosclerosis in patients with acute ischemic stroke by the Coronary Artery Disease consortium models
Objective. To evaluate the validation of models based on the coronary calcium index and the pre-test probability as delineated by the Coronary Artery Disease Consortium for the prediction of obstructive coronary heart disease in patients experiencing acute ischemic stroke. Additionally, the study aims to assess the diagnostic value of high-sensitivity troponin in calculating the risk of obstructive coronary heart disease. Materials and methods. In this prospective registry study, 50 patients (median age 60 years, interquartile range 52 to 66 years) with a confirmed diagnosis of ischemic stroke (IS) underwent computed tomography coronary angiography to identify obstructive coronary artery disease (CAD) (defined as stenosis greater than 50%). A comprehensive assessment of clinical, laboratory, electrocardiographic, and echocardiographic parameters was conducted. The area under the ROC curve (AUC), sensitivity, specificity, predictive value, and calibration of the pre-test probability (PTP) models were analyzed. Results. Obstructive ischemic heart disease was identified in 24 patients (48%) with IS. The Coronary Artery Disease 2 (CAD2) Consortium calcium score (CS) model (CI-CAD2), demonstrated the best discrimination (AUC=0.818, p117 with obstructive CAD, with an OR of 9.220 (95% CI 1.482—57.346, p=0.017). Conclusion. In patients presenting with acute ischemic stroke, incorporating the calcium index into the Coronary Artery Disease Consortium clinical model enhances its accuracy in estimating the pre-test probability of obstructive coronary artery disease. This enhancement is reflected in improved calibration, discrimination, and classification. The coronary calcium index surpasses clinical, laboratory, and echocardiographic parameters in predicting obstructive coronary disease.
- 5 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (7)
Probability of obstructive coronary atherosclerosis in patients with acute ischemic stroke by the Coronary Artery Disease consortium models
Objective. To evaluate the validation of models based on the coronary calcium index and the pre-test probability as delineated by the Coronary Artery Disease Consortium for the prediction of obstructive coronary heart disease in patients experiencing acute ischemic stroke. Additionally, the study aims to assess the diagnostic value of high-sensitivity troponin in calculating the risk of obstructive coronary heart disease. Materials and methods. In this prospective registry study, 50 patients (median age 60 years, interquartile range 52 to 66 years) with a confirmed diagnosis of ischemic stroke (IS) underwent computed tomography coronary angiography to identify obstructive coronary artery disease (CAD) (defined as stenosis greater than 50%). A comprehensive assessment of clinical, laboratory, electrocardiographic, and echocardiographic parameters was conducted. The area under the ROC curve (AUC), sensitivity, specificity, predictive value, and calibration of the pre-test probability (PTP) models were analyzed. Results. Obstructive ischemic heart disease was identified in 24 patients (48%) with IS. The Coronary Artery Disease 2 (CAD2) Consortium calcium score (CS) model (CI-CAD2), demonstrated the best discrimination (AUC=0.818, p117 with obstructive CAD, with an OR of 9.220 (95% CI 1.482—57.346, p=0.017). Conclusion. In patients presenting with acute ischemic stroke, incorporating the calcium index into the Coronary Artery Disease Consortium clinical model enhances its accuracy in estimating the pre-test probability of obstructive coronary artery disease. This enhancement is reflected in improved calibration, discrimination, and classification. The coronary calcium index surpasses clinical, laboratory, and echocardiographic parameters in predicting obstructive coronary disease.
- Open Access
- 25 June 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 172-180
Status of coronary arteries in patients with acute ischemic stroke depending on the presence of myocardial injury
Aim. To assess the frequency of obstructive coronary artery disease (CAD) and coronary calcium score (CCS) measured by coronary computed tomography angiography (CTCA) in patients with IS depending on the presence of myocardial injury (MI), the association between clinical and laboratory parameters and the absence of coronary calcification. Mat erials and methods. In a prospective registry study, 50 patients (median age 60 (52; 66) years) with confirmed IS underwent CTCA. HsTn-I was obtained on admission and repeated within 48 hours. Results. CTCA did not detect significant coronary stenoses in 8 (44.4%) of 18 patients with acute MI, in 3 (33.3%) of 9 patients with chronic MI, and in 15 (65.3%) of 23 patients without MI. In patients with and without MI a CCS was comparable: 143 (0; 266) vs 68 (4; 205), respectively (p = 0.662). There was no statistically significant difference between hsTn levels in CCS categories of CAD risk. In multivariate regression analysis in patients with IS a change (D) in hsTn with a cutoff value of less than -2 ng/L increased odds ratio for absence of coronary calcification by 5.931 times (95% confidence interval 1.129–31.150; p = 0.035). Conclusions. About half of patients with IS and acute MI, 1/3 of patients with chronic MI, and almost 2/3 of patients without MI did not have obstructive CAD. Absolute change in hsTn was independently associated with the absence of coronary calcification in patients with IS.
- 25 June 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 172-180
Open AccessStatus of coronary arteries in patients with acute ischemic stroke depending on the presence of myocardial injury
Aim. To assess the frequency of obstructive coronary artery disease (CAD) and coronary calcium score (CCS) measured by coronary computed tomography angiography (CTCA) in patients with IS depending on the presence of myocardial injury (MI), the association between clinical and laboratory parameters and the absence of coronary calcification. Mat erials and methods. In a prospective registry study, 50 patients (median age 60 (52; 66) years) with confirmed IS underwent CTCA. HsTn-I was obtained on admission and repeated within 48 hours. Results. CTCA did not detect significant coronary stenoses in 8 (44.4%) of 18 patients with acute MI, in 3 (33.3%) of 9 patients with chronic MI, and in 15 (65.3%) of 23 patients without MI. In patients with and without MI a CCS was comparable: 143 (0; 266) vs 68 (4; 205), respectively (p = 0.662). There was no statistically significant difference between hsTn levels in CCS categories of CAD risk. In multivariate regression analysis in patients with IS a change (D) in hsTn with a cutoff value of less than -2 ng/L increased odds ratio for absence of coronary calcification by 5.931 times (95% confidence interval 1.129–31.150; p = 0.035). Conclusions. About half of patients with IS and acute MI, 1/3 of patients with chronic MI, and almost 2/3 of patients without MI did not have obstructive CAD. Absolute change in hsTn was independently associated with the absence of coronary calcification in patients with IS.
- Open Access
- 16 March 2026
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 18 (1) , 101-108
Case report of atypical takotsubo cardiomyopathy complicated by cardiogenic shock
Introduction. The diffuse form of takotsubo cardiomyopathy is extremely rare and even less frequently differentiated from other syndromes. Nevertheless, prompt identification of this condition and a correct emergency care protocol will facilitate proper treatment and minimize complications. Objective. To describe a case of successful use of veno-arterial extracorporeal membrane oxygenation in a patient with cardiogenic shock due to a rare biventricular form of takotsubo cardiomyopathy. Material and methods. The patient, a 55-year-old man, without previous history of chronic disease, was admitted for an abruptly arising atypical form of takotsubo syndrome. The clinical Case Report description utilized laboratory and instrumental tests results from the patient's medical record. Results. The characteristics of the clinical course of the atypical takotsubo syndrome complicated by cardiogenic shock, and the treatment outcomes have been presented. Conclusions. This clinical case review has demonstrated that the Takotsubo syndrome can manifest itself as a diffuse biventricular dysfunction, leading to a life-threatening cardiogenic shock. A multimodal approach using echocardiography, coronary angiography, and cardiac magnetic resonance imaging played an important role in differential diagnosis to distinguish the disease from an acute coronary syndrome and myocarditis. Mechanical circulatory support served as a successful strategy for a rapid and adequate restoration of cardiac contractility. There is a need for heightened vigilance regarding atypical forms of takotsubo syndrome in patients with cardiogenic shock and non-obstructive coronary arteries.
- 16 March 2026
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 18 (1) , 101-108
Open AccessCase report of atypical takotsubo cardiomyopathy complicated by cardiogenic shock
Introduction. The diffuse form of takotsubo cardiomyopathy is extremely rare and even less frequently differentiated from other syndromes. Nevertheless, prompt identification of this condition and a correct emergency care protocol will facilitate proper treatment and minimize complications. Objective. To describe a case of successful use of veno-arterial extracorporeal membrane oxygenation in a patient with cardiogenic shock due to a rare biventricular form of takotsubo cardiomyopathy. Material and methods. The patient, a 55-year-old man, without previous history of chronic disease, was admitted for an abruptly arising atypical form of takotsubo syndrome. The clinical Case Report description utilized laboratory and instrumental tests results from the patient's medical record. Results. The characteristics of the clinical course of the atypical takotsubo syndrome complicated by cardiogenic shock, and the treatment outcomes have been presented. Conclusions. This clinical case review has demonstrated that the Takotsubo syndrome can manifest itself as a diffuse biventricular dysfunction, leading to a life-threatening cardiogenic shock. A multimodal approach using echocardiography, coronary angiography, and cardiac magnetic resonance imaging played an important role in differential diagnosis to distinguish the disease from an acute coronary syndrome and myocarditis. Mechanical circulatory support served as a successful strategy for a rapid and adequate restoration of cardiac contractility. There is a need for heightened vigilance regarding atypical forms of takotsubo syndrome in patients with cardiogenic shock and non-obstructive coronary arteries.
- Open Access
- 14 January 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (5) , 415-422
Plasma concentrations of factor Xa inhibitors and stroke risk in patients with atrial fibrillation
Aim . To determine plasma concentrations of direct oral anticoagulants (DOACs) in patients with ischemic stroke (IS) associated with atrial fibrillation (AF) and to compare them with DOAC levels in patients with AF but without IS receiving similar therapy. Material and methods. A prospective cohort study was conducted at the Vascular Center of S.P. Botkin Moscow City Clinical Hospital from April 2022 to April 2023. The study included 82 patients with cardioembolic stroke on the background of AF (main group) and 130 AF patients without stroke or transient ischemic attack (TIA) (control group). All patients had been receiving DOACs (apixaban or rivaroxaban) for at least 3 months. Diagnostic workup included brain computed tomography, сarotid ultrasound, laboratory tests, and stroke severity assessment by NIH Stroke Scale (NIHSS). Plasma DOAC concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The lower limit of quantification (LLOQ) was 5 ng/mL. Results . Patients in the main group had significantly more frequent subtherapeutic DOAC concentrations below the LLOQ compared to the control group (52.4% vs. 1.5%, pConclusion . A significant proportion of patients with AF and cardioembolic ischemic stroke exhibit plasma concentrations of DOACs below LLOQ, which may contribute to stroke occurrence despite prescribed therapy. These findings emphasize the need to develop clinical criteria for selecting patients who require DOAC concentration monitoring and personalized therapy to reduce the risk of thrombotic events.
- 14 January 2026
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (5) , 415-422
Open AccessPlasma concentrations of factor Xa inhibitors and stroke risk in patients with atrial fibrillation
Aim . To determine plasma concentrations of direct oral anticoagulants (DOACs) in patients with ischemic stroke (IS) associated with atrial fibrillation (AF) and to compare them with DOAC levels in patients with AF but without IS receiving similar therapy. Material and methods. A prospective cohort study was conducted at the Vascular Center of S.P. Botkin Moscow City Clinical Hospital from April 2022 to April 2023. The study included 82 patients with cardioembolic stroke on the background of AF (main group) and 130 AF patients without stroke or transient ischemic attack (TIA) (control group). All patients had been receiving DOACs (apixaban or rivaroxaban) for at least 3 months. Diagnostic workup included brain computed tomography, сarotid ultrasound, laboratory tests, and stroke severity assessment by NIH Stroke Scale (NIHSS). Plasma DOAC concentrations were measured by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The lower limit of quantification (LLOQ) was 5 ng/mL. Results . Patients in the main group had significantly more frequent subtherapeutic DOAC concentrations below the LLOQ compared to the control group (52.4% vs. 1.5%, pConclusion . A significant proportion of patients with AF and cardioembolic ischemic stroke exhibit plasma concentrations of DOACs below LLOQ, which may contribute to stroke occurrence despite prescribed therapy. These findings emphasize the need to develop clinical criteria for selecting patients who require DOAC concentration monitoring and personalized therapy to reduce the risk of thrombotic events.
- Open Access
- 16 November 2025
- Published by Alfmed LLC in Medical alphabet
- No. 27,p. 13-17
Duplex ultrasound of carotid arteries in acute ischemic stroke: efficacy of a screening protocol for assessing indications for carotid endarterectomy
Introduction. Ischemic stroke remains one of the leading causes of mortality and persistent disability worldwide. Early carotid endarterectomy (CEA) within 14 days of symptom onset significantly reduces stroke recurrence in patients with symptomatic carotid stenosis. Rapid and reliable identification of surgical candidates in the acute stroke setting is crucial. This study aimed to develop a short screening protocol for duplex ultrasound of carotid arteries and assess the agreement between the results of the short protocol and those of extended ultrasound examination and computed tomography angiography (CTA) in patients with acute stroke. Materials and methods. This prospective study included 76 patients who were admitted at the Botkin Hospital in 2023–2024 with acute ischemic stroke and who underwent CEA within 14 days of symptom onset. All patients underwent carotid duplex ultrasound using a screening protocol within 30 minutes of admission, assessing stenosis degree per ECST criteria. If stenosis exceeded >50 %, a comprehensive duplex scan was performed. All patients also underwent CTA as part of preoperative workup. Results. The screening protocol identified 50–69 % stenosis in 29 (38 %) patients, 70–99 % stenosis in 41 (54 %), and ICA occlusion in 5 (7 %) patients. Agreement between the shortened and comprehensive duplex protocols was high, with a weighted Cohen’s kappa (κ) of 0.73 (95 % CI 0.59–0.87). Agreement between ultrasound and CTA was also good (κ=0.61 for comprehensive protocol and κ=0.58 for screening protocol). The mean examination time was 15 (±3.2) minutes for the screening protocol and 40 (±6.8) minutes for the standard examination. Conclusion. A shortened, focused duplex ultrasound protocol demonstrates substantial agreement with a comprehensive protocol for grading carotid stenosis in acute stroke patients. The use of the screening protocol significantly reduces examination time without compromising diagnostic accuracy. Implementation of the screening protocol in the emergency hospital setting facilitated the early identification of patients with indications for surgical intervention and the selection of patients for CEA in acute stroke.
- 16 November 2025
- Published by Alfmed LLC in Medical alphabet
- No. 27,p. 13-17
Open AccessDuplex ultrasound of carotid arteries in acute ischemic stroke: efficacy of a screening protocol for assessing indications for carotid endarterectomy
Introduction. Ischemic stroke remains one of the leading causes of mortality and persistent disability worldwide. Early carotid endarterectomy (CEA) within 14 days of symptom onset significantly reduces stroke recurrence in patients with symptomatic carotid stenosis. Rapid and reliable identification of surgical candidates in the acute stroke setting is crucial. This study aimed to develop a short screening protocol for duplex ultrasound of carotid arteries and assess the agreement between the results of the short protocol and those of extended ultrasound examination and computed tomography angiography (CTA) in patients with acute stroke. Materials and methods. This prospective study included 76 patients who were admitted at the Botkin Hospital in 2023–2024 with acute ischemic stroke and who underwent CEA within 14 days of symptom onset. All patients underwent carotid duplex ultrasound using a screening protocol within 30 minutes of admission, assessing stenosis degree per ECST criteria. If stenosis exceeded >50 %, a comprehensive duplex scan was performed. All patients also underwent CTA as part of preoperative workup. Results. The screening protocol identified 50–69 % stenosis in 29 (38 %) patients, 70–99 % stenosis in 41 (54 %), and ICA occlusion in 5 (7 %) patients. Agreement between the shortened and comprehensive duplex protocols was high, with a weighted Cohen’s kappa (κ) of 0.73 (95 % CI 0.59–0.87). Agreement between ultrasound and CTA was also good (κ=0.61 for comprehensive protocol and κ=0.58 for screening protocol). The mean examination time was 15 (±3.2) minutes for the screening protocol and 40 (±6.8) minutes for the standard examination. Conclusion. A shortened, focused duplex ultrasound protocol demonstrates substantial agreement with a comprehensive protocol for grading carotid stenosis in acute stroke patients. The use of the screening protocol significantly reduces examination time without compromising diagnostic accuracy. Implementation of the screening protocol in the emergency hospital setting facilitated the early identification of patients with indications for surgical intervention and the selection of patients for CEA in acute stroke.
- Open Access
- 24 October 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (10S) , 6479
Acute coronary syndrome as a rare manifestation of melanoma with cardiac metastasis: a case report
Introduction. Clinical manifestations of cardiac tumors are nonspecific and can be similar to various cardiovascular diseases. One of the most common sources of secondary cardiac tumors is melanoma. Diagnosis of melanoma with cardiac metastasis is difficult due to the predominantly asymptomatic course. Case description . A case report describes a rare clinical manifestation of melanoma under the guise of acute myocardial infarction in a 51-year-old patient who underwent excision of upper limb melanoma, lymphadenectomy and immunotherapy 5 years ago. The patient was prescribed combination immunotherapy with nivolumab and ipilimumab. Control examination (cardiac magnetic resonance imaging, combined positron emission-computed tomography) after 3 months demonstrated significant regression of the size and metabolic activity of tumor foci both in the heart and in other organs. Discussion. Despite the predominantly asymptomatic course, cardiac metastasis of melanoma can manifest with chest pain, ischemic abnormalities in the ECG and increased cardiac biomarkers, which creates a picture of acute coronary syndrome. The presented case demonstrates the high efficiency of combination immunotherapy in achieving regression of melanoma metastases in the heart and other organs.
- 24 October 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (10S) , 6479
Open AccessAcute coronary syndrome as a rare manifestation of melanoma with cardiac metastasis: a case report
Introduction. Clinical manifestations of cardiac tumors are nonspecific and can be similar to various cardiovascular diseases. One of the most common sources of secondary cardiac tumors is melanoma. Diagnosis of melanoma with cardiac metastasis is difficult due to the predominantly asymptomatic course. Case description . A case report describes a rare clinical manifestation of melanoma under the guise of acute myocardial infarction in a 51-year-old patient who underwent excision of upper limb melanoma, lymphadenectomy and immunotherapy 5 years ago. The patient was prescribed combination immunotherapy with nivolumab and ipilimumab. Control examination (cardiac magnetic resonance imaging, combined positron emission-computed tomography) after 3 months demonstrated significant regression of the size and metabolic activity of tumor foci both in the heart and in other organs. Discussion. Despite the predominantly asymptomatic course, cardiac metastasis of melanoma can manifest with chest pain, ischemic abnormalities in the ECG and increased cardiac biomarkers, which creates a picture of acute coronary syndrome. The presented case demonstrates the high efficiency of combination immunotherapy in achieving regression of melanoma metastases in the heart and other organs.
- Open Access
- 30 June 2025
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (2) , 149-154
Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
Aim. To evaluate the characteristics of anticoagulant therapy (ACT) use in patients with cardioembolic (CE) subtype ischemic stroke (IS) and atrial fibrillation (AF) hospitalized in a specialized vascular center.Material and methods. A cross-sectional study was conducted at the Vascular Center of Botkin City Clinical Hospital from April 2022 to April 2023. Adults (≥18 years) with confirmed CE-subtype IS and documented AF, presenting within 12 hours of symptom onset and receiving anticoagulants for over one month prior to admission, were eligible. Patients with hemorrhagic stroke or non-CE IS subtypes, those lacking data on anticoagulant use, or those who declined to participate were excluded.Results. Among 1.038 patients with IS, 215 (20.7%) were diagnosed with the CE subtype in the setting of AF. More than half (n=109) were not receiving ACT at the time of stroke onset. A total of 106 patients who had been on outpatient ACT were included; rivaroxaban (n=56), apixaban (n=30), dabigatran etexilate (n=11), and warfarin (n=9). The mean patient age was 77.8 years, with an average CHA2DS2-VASc score of 6. In 33.9% of patients, the prescribed doses of direct oral anticoagulant (DOAC) did not correspond to clinical guidelines (e.g., unjustified dose reductions of rivaroxaban and apixaban were identified). The median National Institutes of Health Stroke Scale (NIHSS) score at admission was 7, and in-hospital mortality reached 30.2%. Elevated mortality was associated with severe stroke presentation (NIHSS score > 8 in half of the patients) and a high burden of comorbidities: hypertension in 95.2%, chronic heart failure in 60.4%, type 2 diabetes mellitus in 30.1%, and prior myocardial infarction in 37.7% of patients.Conclusion. The high incidence of IS despite ongoing anticoagulation highlights the need for routine monitoring of DOAC plasma levels, regular assessment of treatment adherence, and systematic education of patients and their families regarding the importance of strict adherence to prescribed anticoagulant regimens.
- 30 June 2025
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 21 (2) , 149-154
Open AccessAnticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
Aim. To evaluate the characteristics of anticoagulant therapy (ACT) use in patients with cardioembolic (CE) subtype ischemic stroke (IS) and atrial fibrillation (AF) hospitalized in a specialized vascular center.Material and methods. A cross-sectional study was conducted at the Vascular Center of Botkin City Clinical Hospital from April 2022 to April 2023. Adults (≥18 years) with confirmed CE-subtype IS and documented AF, presenting within 12 hours of symptom onset and receiving anticoagulants for over one month prior to admission, were eligible. Patients with hemorrhagic stroke or non-CE IS subtypes, those lacking data on anticoagulant use, or those who declined to participate were excluded.Results. Among 1.038 patients with IS, 215 (20.7%) were diagnosed with the CE subtype in the setting of AF. More than half (n=109) were not receiving ACT at the time of stroke onset. A total of 106 patients who had been on outpatient ACT were included; rivaroxaban (n=56), apixaban (n=30), dabigatran etexilate (n=11), and warfarin (n=9). The mean patient age was 77.8 years, with an average CHA2DS2-VASc score of 6. In 33.9% of patients, the prescribed doses of direct oral anticoagulant (DOAC) did not correspond to clinical guidelines (e.g., unjustified dose reductions of rivaroxaban and apixaban were identified). The median National Institutes of Health Stroke Scale (NIHSS) score at admission was 7, and in-hospital mortality reached 30.2%. Elevated mortality was associated with severe stroke presentation (NIHSS score > 8 in half of the patients) and a high burden of comorbidities: hypertension in 95.2%, chronic heart failure in 60.4%, type 2 diabetes mellitus in 30.1%, and prior myocardial infarction in 37.7% of patients.Conclusion. The high incidence of IS despite ongoing anticoagulation highlights the need for routine monitoring of DOAC plasma levels, regular assessment of treatment adherence, and systematic education of patients and their families regarding the importance of strict adherence to prescribed anticoagulant regimens.